Daniel R. Malan
Port Elizabeth, EC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of cosibelimab in advanced cutaneous squamous cell carcinoma: Results from a Pivotal Open-label Study with a median follow-up of ≥2 years.
Journal: Journal of the American Academy of Dermatology
Published: May 28, 2025
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.
Journal: PLOS global public health
Published: June 02, 2024
Efficacy and safety of cosibelimab, an anti-PD-L1 antibody, in metastatic cutaneous squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: September 15, 2023
Long-term safety and efficacy of the anti-tissue factor pathway inhibitor marstacimab in participants with severe haemophilia: Phase II study results.
Journal: British journal of haematology
Published: January 07, 2022
A phase 1b/2 clinical study of marstacimab, targeting human tissue factor pathway inhibitor, in haemophilia.
Journal: British journal of haematology
Published: January 07, 2022
A high-repetition-rate, fast temperature-programmed gas chromatograph and its online coupling to a supercritical fluid chromatograph (SFC × GC).
Journal: The Review of scientific instruments
Published: April 09, 2020
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
Journal: Journal of thrombosis and haemostasis : JTH
Published: February 27, 2018
Hyphenation of supercritical fluid chromatography and two-dimensional gas chromatography-mass spectrometry for group type separations.
Journal: Journal of chromatography. A
Published: February 05, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026